NRx Pharmaceuticals, Inc. (NRXP) — Dilution Risk Analysis
Current Snapshot
NRx Pharmaceuticals, Inc. (NRXP) has a DilutionWatch score of 43/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 43/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: XBRL 2, 8-K 3, 424B5 1, 3 1, 4 1.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-5943-xbrl_warrant |
| 8-K | 2026-03-24 | 0001437749-26-009611 |
| 424B5 | 2026-02-17 | 0001437749-26-004244 |
| 8-K | 2026-02-17 | 0001437749-26-004245 |
| 3 | 2026-02-17 | 0001437749-26-004425 |
| 4 | 2026-02-17 | 0001437749-26-004426 |
| xbrl | 2025-12-31 | xbrl-5943-xbrl_convertible |
| 8-K | 2025-12-29 | 0001437749-25-038835 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $20,000,000 | Source |
| Cash runway | 18 months | Source |
| Three-year share count growth | 312.74% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 43/10) Source
- Cash Runway
- 18 months Source
- ATM Offering Capacity Remaining
- $20,000,000 Source
- Share Count Growth (3-Year)
- 312.74% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.